More News

19 Nov 2019 Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
19 Nov 2019 Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies
19 Nov 2019 Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel
19 Nov 2019 Alkermes to Acquire Rodin Therapeutics
19 Nov 2019 Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
16 Nov 2019 Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
14 Nov 2019 Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
14 Nov 2019 Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
14 Nov 2019 Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York
14 Nov 2019 Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
14 Nov 2019 Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
13 Nov 2019 Avidity Biosciences Completes $100 Million Series C Financing
13 Nov 2019 COI Pharmaceuticals Announces Acquisition of Calporta by Merck
12 Nov 2019 bluebird bio and Forty Seven Announce a Research Collaboration to Study an All Antibody Conditioning Regimen for Use in Combination with Autologous Lentiviral Vector Hematopoietic Stem Cell Gene Therapy
11 Nov 2019 Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
11 Nov 2019 UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
09 Nov 2019 Akeso, Inc. Completed Series-D Private Financing for close to US$150 Million
09 Nov 2019 Ningbo Tai Kang Medical Technology Co., Ltd Announces Global Licensing Agreement With AstraZeneca
07 Nov 2019 Bayer invests USD 50 Million in eGenesis Series B financing round
07 Nov 2019 Novo Nordisk obtains exclusive worldwide licence to potential NASH candidate UD-014 from UBE Industries
07 Nov 2019 Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
07 Nov 2019 Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
07 Nov 2019 Alvotech and STADA Agree on Strategic Biosimilar Partnership
06 Nov 2019 Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
06 Nov 2019 Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up